| A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence | 2021-08-10 | 2023-06-14 | |
| Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia | 2022-06-09 | 2023-04-04 | |
| A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines | 2022-03-08 | 2023-02-01 | |
| A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence | 2021-07-08 | 2022-12-20 | |
| A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines | 2021-10-06 | 2022-12-02 | |
| A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines | 2021-11-29 | 2022-09-06 | |
| Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. | 2021-03-05 | 2022-08-04 | 2023-08-03 |
| A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines | 2021-09-01 | 2022-07-07 | |
| A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease | 2020-03-04 | 2022-03-18 | |
| A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily | 2021-09-02 | 2022-02-11 | 2023-02-06 |
| OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17) | 2014-05-23 | 2022-02-10 | 2022-10-07 |
| Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine | 2019-03-11 | 2022-01-20 | 2023-01-18 |
| Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine | 2021-08-02 | 2022-01-20 | 2023-03-09 |
| A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age | 2021-05-14 | 2021-12-07 | |
| A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants | 2020-05-19 | 2021-06-24 | 2022-06-17 |
| A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants | 2019-10-11 | 2021-06-22 | 2024-05-09 |
| Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease | 2020-06-29 | 2021-06-15 | |
| Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation | 2019-10-14 | 2021-04-20 | 2022-03-31 |
| Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine | 2019-05-06 | 2021-03-31 | 2022-03-15 |
| Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder | 2018-07-06 | 2021-03-01 | 2022-03-01 |
| A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension | 2016-02-24 | 2021-01-26 | 2022-01-25 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 | 2018-02-01 | 2020-11-05 | 2021-10-05 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 | 2018-01-24 | 2020-10-30 | 2021-10-05 |
| Diabetic Gastroparesis Study 05 | 2018-12-20 | 2020-10-05 | 2021-10-05 |
| A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia | 2019-03-01 | 2020-09-10 | 2021-11-27 |
| AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines | 2019-09-26 | 2020-09-09 | 2023-07-10 |
| A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment | 2019-01-22 | 2020-07-29 | 2021-07-29 |
| BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence | 2017-10-04 | 2020-07-21 | 2021-07-21 |
| JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness | 2018-11-09 | 2020-07-17 | 2022-10-13 |
| Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 | 2018-02-16 | 2020-07-16 | 2021-07-15 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 | 2017-09-29 | 2020-07-08 | 2021-07-08 |
| 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine | 2018-12-14 | 2020-06-19 | 2021-06-18 |
| Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine | 2018-10-08 | 2020-05-21 | 2021-05-20 |
| Eluxadoline Bile Acid Malabsorption (BAM) Study | 2018-02-23 | 2020-04-28 | 2021-04-28 |
| BOTOX® for the Treatment of Platysma Prominence | 2019-04-23 | 2020-04-16 | 2023-04-11 |
| BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence | 2019-05-16 | 2020-04-03 | 2021-04-02 |
| Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour | 2018-02-02 | 2019-12-05 | 2020-12-04 |
| Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia | 2018-12-21 | 2019-10-31 | 2021-11-27 |
| Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | 2016-11-29 | 2019-03-29 | 2020-03-27 |
| A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) | 2018-05-25 | 2019-02-27 | 2020-07-17 |
| A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity | 2014-01-11 | 2018-11-22 | 2020-04-22 |
| Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | 2017-07-24 | 2018-10-30 | 2019-10-30 |
| Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension | 2014-12-15 | 2018-10-25 | 2021-04-29 |
| A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital Hollowing | 2018-01-26 | 2018-10-17 | 2021-10-15 |
| Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients | 2013-07-02 | 2018-10-11 | 2019-10-11 |
| An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine | 2016-09-13 | 2018-08-02 | 2019-08-02 |
| Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty | 2018-05-08 | 2018-07-10 | 2019-07-02 |
| A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula | 2018-02-05 | 2018-05-29 | 2019-05-29 |
| A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | 2015-06-25 | 2018-04-18 | 2020-07-16 |
| Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | 2015-06-25 | 2018-04-12 | 2020-07-17 |